Pfizer Inc

Healthcare · Drug Manufacturers - General

28.40$ +0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Ratios

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Last 12 Full history

Download as CSV

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios PFE
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Valuation
P/E (price/earnings)	31.7	26.4	27.2	23.2	20.9	9.8	9.4	9.1	10.5	21.5	20.2	18.4	11.9	12.9	11.0	12.3	24.6	22.7	19.2	17.1	12.5	15.3	11.8	10.2	8.4	9.4	8.0	9.8	17.9	76.3	–	–	38.6	18.8	18.4	12.8	14.8	18.2	21.5	31.7
P/S (price/sales)	3.7	3.6	3.8	3.7	3.9	4.0	3.9	3.9	4.7	4.5	4.3	4.3	3.6	4.0	3.6	3.8	4.6	5.0	4.4	4.0	3.6	4.2	3.2	3.0	2.5	2.9	2.5	2.7	2.7	2.7	2.8	2.8	2.7	2.4	2.3	2.2	2.3	2.3	2.5	2.2
P/B (price/book)	3.1	3.2	3.4	3.3	3.4	2.9	2.9	2.9	3.5	3.8	3.9	3.9	3.0	3.3	2.7	2.7	3.0	3.3	3.0	3.2	3.3	4.4	3.6	3.4	2.7	3.1	2.3	2.1	1.9	1.8	1.7	1.8	1.8	1.7	1.6	1.6	1.6	1.6	1.8	1.6
EV/Revenue	4.5	4.3	4.5	4.5	4.7	4.8	4.6	4.6	5.5	5.2	5.1	5.2	4.6	5.0	4.6	5.2	6.0	5.9	5.2	4.7	4.1	4.6	3.6	3.3	2.9	3.3	2.9	3.5	3.6	3.9	4.1	4.0	3.8	3.4	3.3	3.1	3.3	3.3	3.5	3.1
EV/EBITDA	15.0	15.0	15.0	13.4	12.5	12.6	12.1	11.7	13.8	14.3	13.9	14.3	9.3	10.3	9.5	10.7	22.6	18.8	15.2	12.9	10.4	12.3	9.8	8.8	7.3	8.0	6.9	9.1	13.6	24.6	31.1	41.4	16.7	10.3	10.3	8.7	9.7	12.2	13.3	15.8
Price/Free Cash Flow	15.5	13.6	14.3	14.3	15.2	14.6	14.0	13.4	16.0	17.6	17.7	19.8	17.7	21.0	15.0	13.8	19.0	17.9	15.8	10.8	8.4	11.4	9.4	10.5	10.7	11.3	11.6	19.7	22.9	33.9	31.0	33.2	20.0	15.4	12.9	11.1	14.0	15.6	17.0	12.5
FCF yield	6.5%	7.3%	7.0%	7.0%	6.6%	6.8%	7.2%	7.4%	6.3%	5.7%	5.7%	5.0%	5.7%	4.8%	6.7%	7.2%	5.3%	5.6%	6.3%	9.3%	11.9%	8.8%	10.7%	9.5%	9.3%	8.9%	8.6%	5.1%	4.4%	2.9%	3.2%	3.0%	5.0%	6.5%	7.8%	9.0%	7.1%	6.4%	5.9%	8.0%
Margins
Gross margin	74.8%	73.2%	71.6%	70.2%	70.3%	69.9%	69.8%	69.7%	69.8%	70.1%	70.5%	71.0%	70.9%	71.5%	71.4%	71.6%	72.2%	71.3%	69.3%	65.0%	60.4%	57.7%	56.5%	59.1%	62.4%	62.4%	64.7%	65.4%	55.5%	52.1%	51.8%	49.1%	58.7%	66.8%	66.9%	67.3%	71.2%	70.3%	69.3%	71.3%
Operating margin	25.8%	26.6%	26.9%	27.2%	27.5%	27.4%	27.1%	27.2%	27.2%	28.4%	29.2%	29.5%	28.9%	27.3%	26.1%	24.3%	23.7%	21.6%	23.2%	25.7%	28.2%	26.9%	29.3%	33.6%	36.0%	37.9%	37.2%	30.7%	16.4%	7.9%	4.6%	3.9%	16.8%	26.9%	27.5%	29.6%	27.8%	24.7%	23.4%	25.1%
Net margin	11.7%	13.6%	13.8%	15.8%	18.7%	40.6%	41.3%	42.3%	44.6%	20.8%	21.3%	23.6%	30.6%	31.4%	32.3%	31.3%	18.6%	21.9%	23.1%	23.5%	28.5%	27.3%	27.3%	28.9%	29.8%	31.3%	31.2%	27.5%	15.2%	3.6%	-0.5%	-4.6%	7.1%	12.6%	12.6%	16.8%	15.6%	12.4%	11.8%	6.8%
FCF margin	23.9%	26.3%	26.2%	25.7%	25.7%	27.1%	27.8%	28.6%	29.3%	25.4%	24.3%	21.9%	20.5%	19.3%	23.7%	27.8%	24.0%	27.7%	28.0%	37.3%	42.4%	36.7%	34.4%	28.1%	23.4%	25.9%	21.7%	13.6%	11.9%	8.1%	9.2%	8.6%	13.6%	15.5%	18.0%	19.5%	16.5%	14.5%	15.0%	17.2%
Returns
Return on equity (ROE)	9.8%	12.1%	12.4%	14.2%	16.1%	29.9%	31.0%	32.3%	33.4%	17.6%	19.5%	21.2%	24.9%	25.8%	24.2%	22.1%	12.2%	14.5%	15.6%	18.5%	26.0%	28.8%	30.6%	33.6%	32.1%	32.8%	28.8%	21.7%	10.8%	2.4%	-0.3%	-3.0%	4.6%	9.1%	8.7%	12.1%	10.6%	9.0%	8.3%	5.1%
Return on assets (ROA)	3.5%	4.2%	4.3%	4.9%	5.7%	12.4%	13.2%	13.7%	14.2%	7.0%	7.4%	8.1%	9.5%	9.7%	9.5%	8.0%	4.5%	5.9%	6.7%	7.6%	11.0%	12.2%	13.7%	15.0%	15.2%	15.9%	14.8%	9.8%	4.9%	0.9%	-0.1%	-1.2%	1.9%	3.8%	3.8%	5.2%	4.7%	3.7%	3.6%	2.2%
Balance Sheet & Debt
Net debt	41,976	39,466	39,953	41,120	41,172	42,136	38,530	37,818	44,873	40,606	43,207	44,890	49,869	51,024	50,134	61,811	61,562	38,052	37,931	35,363	37,913	36,492	33,822	38,479	35,355	35,413	33,727	62,709	60,448	69,006	68,464	67,625	65,525	62,606	59,861	59,287	59,505	63,149	62,027	62,218
Net debt/EBITDA	2.6	2.6	2.5	2.4	2.1	2.1	1.9	1.8	2.1	2.1	2.2	2.3	1.9	2.0	2.1	2.8	5.4	2.9	2.4	1.8	1.4	1.2	1.0	1.0	0.9	0.9	0.9	2.1	3.3	7.3	9.4	12.3	4.7	3.0	3.0	2.6	2.8	3.8	3.7	4.9
Equity ratio	35.5%	34.7%	34.6%	34.6%	35.3%	41.5%	42.6%	42.3%	42.5%	39.8%	37.8%	38.1%	38.2%	37.7%	39.1%	36.2%	36.5%	41.0%	43.2%	41.2%	42.2%	42.5%	44.8%	44.7%	47.4%	48.5%	51.6%	45.0%	45.1%	39.3%	41.7%	40.6%	42.0%	41.3%	43.4%	43.0%	44.5%	41.5%	43.4%	42.4%
Debt/equity	0.7	0.7	0.8	0.7	0.7	0.6	0.6	0.6	0.7	0.7	0.8	0.8	0.8	0.8	0.8	1.0	1.0	0.6	0.6	0.5	0.5	0.5	0.4	0.5	0.4	0.4	0.4	0.7	0.7	0.8	0.7	0.8	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7
Per Share
Earnings per share (EPS)	1.02	1.17	1.19	1.37	1.62	3.51	3.59	3.79	3.98	1.93	2.00	2.23	2.87	2.89	2.80	2.52	1.42	1.62	1.89	2.29	3.44	3.85	4.38	5.13	5.21	5.46	5.07	3.76	1.85	0.38	-0.05	-0.46	0.75	1.41	1.38	1.88	1.72	1.37	1.31	0.76
Revenue per share	8.67	8.60	8.63	8.67	8.69	8.67	8.70	8.95	8.92	9.27	9.37	9.46	9.39	9.19	8.68	8.06	7.62	7.39	8.18	9.74	12.07	14.09	16.05	17.73	17.47	17.47	16.27	13.68	12.22	10.50	9.77	9.87	10.59	11.16	10.94	11.19	10.99	11.01	11.05	11.18
Book value per share	10.31	9.69	9.59	9.67	10.06	11.76	11.59	11.72	11.91	10.95	10.23	10.50	11.52	11.21	11.58	11.45	11.59	11.17	12.12	12.34	13.22	13.38	14.31	15.27	16.20	16.66	17.63	17.33	17.17	15.76	16.20	15.40	16.18	15.47	15.82	15.54	16.24	15.21	15.72	14.95
Free cash flow per share	2.08	2.26	2.26	2.23	2.23	2.35	2.41	2.56	2.62	2.36	2.28	2.07	1.93	1.77	2.06	2.24	1.83	2.05	2.29	3.64	5.12	5.18	5.52	4.98	4.09	4.53	3.53	1.87	1.45	0.85	0.90	0.84	1.44	1.72	1.96	2.18	1.82	1.60	1.65	1.93

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Ratios

Cookie settings